America’s health care prices are out of control. These 11 charts prove it.

Humira is an injectable medication used to treat multiple autoimmune diseases, that range from rheumatoid arthritis to psoriasis to ulcerative colitis — and one of the best-selling drugs in American history. In 2014 alone, millions of Americans spent a combined $6.5 billion on Humira prescriptions.

But we probably didn’t have to. While Americans paid an average price of $2,669 for Humira, the Swiss were able to buy the exact same drug for $822 — and in the United Kingdom, patients got it for $1,362. If the United States paid what the Swiss paid for the arthritis drug, we would have spent $2 billion on Humira in 2014 rather than $6.5 billion.

There’s nothing different about the Humira that we bought in the United States and the drug the Swiss bought – except that in the United States, we’re terrible at negotiating a good deal on pretty much any medical service.

“It’s exactly the same product, but, in terms of the American patient, you’re just paying double or more the price for no more health gain,” says Tom Sackville, chief executive of the International Federation of Health Plans.

Every two years, his group publishes a report that compares health care prices in different countries. And it shows that Humira isn’t some weird anomaly; nearly every procedure or drug costs way more in the United States. See for yourself in these charts:

Humira, a medication for multiple forms of arthritis, skin conditions, and inflammatory bowel diseases, costs three times as much in the United States as in Switzerland.

Harvoni cures hepatitis C. It also costs $10,000 more in the US than anywhere else.

Need to take the cancer drug Avastin? It will cost nine times more in the United States than in Britain.

An MRI costs twice as much here as in Switzerland.

A day in a hospital costs $5,220 here — versus $424 in Spain.

You may want to consider appendix removal in Australia — it will be about $12,000 cheaper.

At this point, it will be no surprise that a normal delivery in the United States is quite expensive too.

The same is true for C-section procedures — they cost twice as much here as in Australia.

And for cataract surgery — it’s more expensive in the United States than anywhere else.

Bypass surgery costs $78,318 here, versus $24,059 in the UK.

The same goes for another common procedure, knee replacements.

Americans use the doctor less than people in other countries. We still pay more for health care.

The United States is routinely the most expensive place to buy medical care, whether that’s a Humira pen or a knee replacement or an MRI scan. There are a handful of exceptions to the rule: The US does have colonoscopies that are cheaper than in New Zealand or the United Kingdom. On CT scans, we also come in slightly cheaper than Britain. But aside from those examples, it’s generally a safe bet that the highest prices for medical care can be found in America.

The IFHP report undercut a common misconception about American health care: that it’s more expensive because we use more of it. Americans actually tend to use slightly less health care than people living elsewhere. We go to the doctor less, for example, and have fewer hospitals per capita than most European countries.

Americans spend more for health care largely because of the prices.

Most other countries have some central body that negotiates prices with hospitals and drug manufacturers. Sackville, who used to work for Britain’s health care system, recalls that it had a unit of 14 people whose whole job was getting drug manufacturers to give the country a better deal on prescription medications.

That unit of 14 is essentially buying in bulk for a country of 63 million people – and can successfully ask for steep discounts in return.

The United States doesn’t have that type of agency. Every insurance plan negotiates individually with hospitals, doctors, and pharmaceutical company to set prices. Insurers in the United States don’t, as these charts show, get a bulk discount. Instead, our fragmented system means that Americans pay more for every type of health care that IFHP measured.

“You could say that American health care providers and pharmaceuticals are essentially taking advantage of the American public because they have such a fragmented system,” Sackville said. “The system is so divided, it’s easy to conquer.”

What would make these charts look different? How could the United States end up more in the middle of the pack? The simplest answer is that it could start handling drug negotiations like other countries, and set up a body that negotiates prices for the country. Right now we leave those negotiations up to health insurance plans. And the health insurance plans tend to lose.

Defenders of the American system argue that these types of price controls stifle innovation. Many say that our higher spending creates financial incentives for drug companies to come up with wonderful new drugs. And they’re probably right: More money paid to pharmaceutical companies does give them additional liberty to experiment and come up with new treatments. But that means we’re paying higher prices to subsidize drugs for the rest of the world. It also means that some of the treatments pharmaceutical companies develop will be out of reach of many Americans when they do come to market.